PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease ReportsSyphilis
MeSH D013587 - syphilis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D014211:Treponemal infections
0 Companies
0 Drugs
Success rate
D015231:Bacterial sexually transmitted diseases
0 Companies
0 Drugs
Success rate
D013587: 
Syphilis
D002601:Chancre
0 Companies
0 Drugs
Success rate
D009494:Neurosyphilis
$
Success rate
D013589:Cardiovascular syphilis
0 Companies
0 Drugs
Success rate
D013590:Congenital syphilis
0 Companies
0 Drugs
Success rate
D013591:Cutaneous syphilis
0 Companies
0 Drugs
Success rate
D013592:Latent syphilis
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
A.H. Robins CompanyTetracycline Tetracycline  1982-01-01   
Abbott BiotherapeuticsTetracycline Tetracycline  1982-01-01   
Acella PharmaceuticalsDoxycycline hyclate Doxycycline Hyclate  2020-03-16   
Ajanta PharmaDoxycycline hyclate Doxycycline Hyclate  2018-09-24   
Alembic PharmaceuticalsDoxycycline Doxycycline  2017-07-28   
Doxycycline hyclate Doxycycline Hyclate  2018-06-13   
AllerganDoxycycline Doxycycline  2000-04-28   
Doxycycline hyclate Doxycycline Hyclate  1982-01-01   
Tetracycline Tetracycline  1982-01-01   
Penicillin g Penicillin G  1988-09-13   
Penicillin g Penicillin G Potassium  1988-09-13   
AlpharmaTetracycline Tetracycline  1982-01-01   
1
2
3
4
5
6
...
10
>
Clinical Trials
Historical Success Rate
Phase 1
100%
6/6
Phase 2
100%
6/6
Phase 3
84%
16/19
Approved: 9Overall Success rate: 84%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Abbott Biotherapeutics
Allergan
1
2
3
4
5
6
7
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use